Tony Luongo MD, FRCSC, FACS

Dr. Tony Luongo is a Staff Urologists and an Assistant Professor, Department of Urology at Tufts Medical Center, since July 2008. At Tufts, Dr. Luongo has developed a large clinical practice with a focus on urologic oncology and robotic/laparoscopic surgery particularly in the area of prostate and bladder cancer.  He is also the Director of the Genitourinary Oncology Group at Tufts which oversees, directs, and manages patient care, research, and resident/fellows education/training in urologic cancers. Prior to this appointment, Dr. Luongo was an Assistant Professor in the department of urology at the University of Miami/Jackson Memorial Hospital from 2006 to 2008. He has been a Principal or Co-Investigator for multiple clinical trials in prostate and bladder cancer, including the study of Myriad’s Prolaris genomic test in newly diagnosed prostate cancer, Sipuleucel-T, Enzalutamide, Abiraterone, and Tasquinimod in advanced prostate cancer.

Dr. Luongo graduated from medical school at the University of British Columbia Vancouver, BC in 1999. Dr. Luongo then completed his Urology residency at UBC/Vancouver Health Science Center in 2004 and Urologic oncology fellowship at the University of Texas, MD Anderson Cancer Center, Houston, Texas in 2006. 

Dr. Luongo is an active member of the AUA, SUO, ASCO, and Society of Robotic Surgeons.  He currently serves on the editorial board American Journal of Clinical Oncology and Current Urology Reports.  He has published numerous medical and scientific publications and has presented in many regional and national conferences primarily in the area of prostate and bladder cancer.

Dr. Luongo was the recipient of Tufts University School of Medicine Young Investigator Award from 2008 to 2010 and American Foundation of Urologic Diseases Research Scholar Award from 2004 to 2006.  He was also awarded University of Miami Department of Urology Resident Teaching Award in 2008.